2025-523411-11-00Not yet recruitingPhase 1
An open label, balanced, randomized, three treatment, three period, three sequence, single dose, crossover study to assess the effect of food and effect of apple sauce on bioavailability of the Test product (Bupropion Hydrochloride Extended Release Capsules 150 mg, manufactured by Sun Pharmaceutical Industries Limited, India) in healthy, adult, human subjects.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 May 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 28 Jan 2026
- Start date
- 1 Jun 2026
- Lead sponsor
- Sun Pharmaceutical Industries Limited
- EU CT number
- 2025-523411-11-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 72
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Terapia S.A. | Cluj-Napoca | Romania | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.